Brief Report

Control of massive bleeding in dengue hemorrhagic fever with severe thrombocytopenia by use of intravenous anti-D globulin

Corresponding Author

Satya P. Yadav DCH, DNB

[email protected]

Pediatric Hematology and Oncology Unit, Department of Pediatrics, Center For Child Health, Sir Ganga Ram Hospital, New Delhi, India

Consultant, Pediatric Hematology and Oncology Unit, Department of Pediatrics, Center For Child Health, Sir Ganga Ram Hospital, New Delhi 110060, India.===Search for more papers by this author

Anupam Sachdeva DCH, MD,

Anupam Sachdeva DCH, MD

Pediatric Hematology and Oncology Unit, Department of Pediatrics, Center For Child Health, Sir Ganga Ram Hospital, New Delhi, India

Search for more papers by this author

Dhiren Gupta MD,

Dhiren Gupta MD

Pediatric Intensive Care Unit, Department of Pediatrics, Center For Child Health, Sir Ganga Ram Hospital, New Delhi, India

Search for more papers by this author

Sunil D. Sharma MBBS, DCH,

Sunil D. Sharma MBBS, DCH

Pediatric Hematology and Oncology Unit, Department of Pediatrics, Center For Child Health, Sir Ganga Ram Hospital, New Delhi, India

Search for more papers by this author

Gaurav Kharya MBBS, DCH,

Gaurav Kharya MBBS, DCH

Pediatric Hematology and Oncology Unit, Department of Pediatrics, Center For Child Health, Sir Ganga Ram Hospital, New Delhi, India

Search for more papers by this author

Satya P. Yadav DCH, DNB,

Corresponding Author

Satya P. Yadav DCH, DNB

[email protected]

Pediatric Hematology and Oncology Unit, Department of Pediatrics, Center For Child Health, Sir Ganga Ram Hospital, New Delhi, India

Consultant, Pediatric Hematology and Oncology Unit, Department of Pediatrics, Center For Child Health, Sir Ganga Ram Hospital, New Delhi 110060, India.===Search for more papers by this author

Anupam Sachdeva DCH, MD,

Anupam Sachdeva DCH, MD

Pediatric Hematology and Oncology Unit, Department of Pediatrics, Center For Child Health, Sir Ganga Ram Hospital, New Delhi, India

Search for more papers by this author

Dhiren Gupta MD,

Dhiren Gupta MD

Pediatric Intensive Care Unit, Department of Pediatrics, Center For Child Health, Sir Ganga Ram Hospital, New Delhi, India

Search for more papers by this author

Sunil D. Sharma MBBS, DCH,

Sunil D. Sharma MBBS, DCH

Pediatric Hematology and Oncology Unit, Department of Pediatrics, Center For Child Health, Sir Ganga Ram Hospital, New Delhi, India

Search for more papers by this author

Gaurav Kharya MBBS, DCH,

Gaurav Kharya MBBS, DCH

Pediatric Hematology and Oncology Unit, Department of Pediatrics, Center For Child Health, Sir Ganga Ram Hospital, New Delhi, India

Search for more papers by this author

First published: 09 October 2008

https://doi.org/10.1002/pbc.21708

Citations: 8

Share a link

Email
Wechat
Bluesky

Abstract

Dengue hemorrhagic fever (DHF) is a potentially lethal complication of mosquito borne viral disease, Dengue Fever. Thrombocytopenia is a constant finding in DHF/Dengue Shock Syndrome (DSS). We report two cases that fulfilled the WHO criteria of DSS: high fever, positive tourniquet test, severe thrombocytopenia (<10,000/mm³), hemo-concentration (Hematocrit increase >20%), hypotension and bleeding refractory to routine therapeutic measures, who showed dramatic improvement after receiving Intravenous Anti-D globulin (IV anti-D). Pediatr Blood Cancer 2008;51:812–813. © 2008 Wiley-Liss, Inc.

REFERENCES

1 World Health Organization. Dengue hemorrhagic fever: Diagnosis, treatment and control, 2nd edition. Geneva: WHO Geneva Publication; 1997. pp 12–23.
Google Scholar
2 World Health Organization. Dengue/dengue hemorrhagic fever. Wkly Epidemiol Rec 2000; 75: 193–196.
PubMed Google Scholar
3 Saito M, Oishi K, Inoue S, et al. Association of increased platelet-associated immunoglobulins with thrombocytopenia and the severity of disease in secondary dengue virus infections. Clin Exp Immunol 2004; 138: 299–303.
10.1111/j.1365-2249.2004.02626.x
CAS PubMed Web of Science® Google Scholar
4 Mitrakul C. Hemostatic and platelet kinetic studies in dengue hemorrhagic fever. Am J Trop Med Hyg 1979; 26: 975–984.
PubMed Web of Science® Google Scholar
5 Boonpucknavig S. Demonstration of dengue antibody complexes on the surface of platelet from patients with dengue hemorrhagic fever. Am J Trop Med Hyg 1979; 28: 881–884.
10.4269/ajtmh.1979.28.881
PubMed Web of Science® Google Scholar
6 Mitrakul C, Poshyachinda M, Futrakul P, et al. Hemostatic and platelet kinetic studies in dengue hemorrhagic fever. Am J Trop Med Hyg 1977; 26: 975–984.
CAS PubMed Web of Science® Google Scholar
7 Isarangkura PB, Pongpanich B, Pintadit P, et al. Hemostatic derangement in dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health 1987; 18: 331–339.
CAS PubMed Google Scholar
8 Krishnamurit C, Kalayanarooj S, Cutting MA, et al. Mechanism of hemorrhage in dengue without circulatory collapse. Am J Trop Med Hyg 2001; 65: 840–847.
PubMed Web of Science® Google Scholar
9 Chuansumrit A, Wangruangsatid S, Lektrakul Y, et al. Control of bleeding in children with dengue hemorrhagic fever using recombinant activated factor VII: A randomized, double blind, placebo-controlled study. Blood Coagul Fibrinolysis 2005; 16: 549–555.
10.1097/01.mbc.0000186837.78432.2f
CAS PubMed Web of Science® Google Scholar
10 De Castro RA, de Castro JA, Barez MY, et al. Thrombocytopenia associated with dengue hemorrhagic fever responds to intravenous administration anti D (Rh-D) antiglobulin. Am J Trop Med Hyg 2007; 76: 737–742.
PubMed Web of Science® Google Scholar

Citing Literature

Volume51, Issue6

December 2008

Pages 812-813

Control of massive bleeding in dengue hemorrhagic fever with severe thrombocytopenia by use of intravenous anti-D globulin

Abstract

REFERENCES

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Control of massive bleeding in dengue hemorrhagic fever with severe thrombocytopenia by use of intravenous anti-D globulin

Abstract

REFERENCES

Citing Literature

References

Related

Information